Atara Biotherapeutics Q1 Earnings Show Lower Than Expected GAAP EPS and Revenue Figures
Thursday, 28 March 2024, 12:43
Atara Biotherapeutics Q1 Earnings Overview
Atara Biotherapeutics recently disclosed its financial performance for the first quarter of the year, showing significant discrepancies in GAAP EPS and revenue figures.
Key Highlights:
- GAAP EPS: Recorded at -$0.56, missing estimates by $0.03.
- Revenue: Reported as $4.25M, falling short by a substantial $10.01M.
These disappointing results indicate potential challenges for the company moving forward, prompting investors to reconsider their positions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.